Privi Biotechnologies Profile
Key Indicators
- Authorised Capital ₹ 40.00 Cr
as on 30-07-2024
- Paid Up Capital ₹ 36.27 Cr
as on 30-07-2024
- Company Age 39 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.75 M
as on 30-07-2024
- Satisfied Charges ₹ 22.20 Cr
as on 30-07-2024
- Revenue 21.08%
(FY 2023)
- Profit 67.29%
(FY 2023)
- Ebitda 113.03%
(FY 2023)
- Net Worth -3.66%
(FY 2023)
- Total Assets -3.59%
(FY 2023)
About Privi Biotechnologies
The Corporate was formerly known as Prime Machine Company Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 40.00 Cr and a paid-up capital of Rs 36.27 Cr.
The company currently has active open charges totaling ₹8.75 M. The company has closed loans amounting to ₹22.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Privi Biotechnologies Private Limited India are Narayan Iyer as CFO and Ashwini Vichare as Company Secretary. Mahesh Babani and Bhaktavatsala Doppalapudi serve as directors at the Company.
- CIN/LLPIN
U74220MH1985PTC037534
- Company No.
037534
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 1985
- Date of AGM
04 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Privi Biotechnologies?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhaktavatsala Doppalapudi  | Managing Director | 06-Aug-2011 | Current |
| Narayan Iyer | CFO | 14-Mar-2019 | Current |
| Ashwini Vichare | Company Secretary | 30-Jan-2023 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mahesh Babani | Director | 06-Aug-2011 | Current |
Financial Performance and Corporate Structure Insights of Privi Biotechnologies.
Privi Biotechnologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.08% increase. The company also saw a substantial improvement in profitability, with a 67.29% increase in profit. The company's net worth dipped by a decrease of 3.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Privi Biotechnologies?
In 2023, Privi Biotechnologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Privi Speciality Chemicals LimitedActive 39 years 6 monthsMahesh Babani, Bhaktavatsala Doppalapudi and 2 more are mutual person
- Vivira Investment And Trading Private LimitedActive 34 years 10 months
Bhaktavatsala Doppalapudi is a mutual person
- Satellite Technologies Private LimitedActive 12 years 4 months
Mahesh Babani and Bhaktavatsala Doppalapudi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Mar 2016 | ₹8.75 M | Open |
Others Creation Date: 24 Jul 2018 | ₹4.20 Cr | Satisfied |
Rbl Bank Limited Creation Date: 03 Nov 2014 | ₹15.00 Cr | Satisfied |
How Many Employees Work at Privi Biotechnologies?
Privi Biotechnologies has a workforce of 38 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Privi Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Privi Biotechnologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
